Psychotherapy vs antidepressants in heart failure: Impact of adherence
Journal of Affective Disorders · 2026-12 · 414 · 122318
DOI: 10.1016/j.jad.2026.122318 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026-12. Verfasst von Waguih William IsHak und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA(1); David Geffen School of Medicine at UCLA,…. Hauptthemen laut MEDLINE: Heart Failure, Antidepressive Agents, Depressive Disorder, Psychotherapy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Patient-Centered Outcomes Research Institute.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Depression affects nearly half of patients with heart failure (HF), which is associated with increased morbidity and reduced health-related quality of life (HRQoL). This secondary per-protocol analysis of a previously published randomized trial evaluated the behavioral activation (BA) versus antidepressant medication (MEDS) among patients with depression and HF who adhered to study interventions. METHODS: This analysis is based on a pragmatic randomized comparative-effectiveness trial conducted from 2018 to 2022, with a 1-year follow-up. 416 participants diagnosed with HF and a DSM-5 depressive disorder were randomized to BA or MEDS, and the current analysis examined outcomes according to treatment adherence. OUTCOMES: The primary outcome was depressive symptom severity (PHQ-9) at 6 months, and the secondary outcomes were physical and mental HRQoL (SF-12v2-PC and SF-12v2-MC, respectively) and HF-specific HRQoL (Kansas City Cardiomyopathy Questionnaire; KCCQ) overall and clinical scores (KCCQ-OS and KCCQ-CS), at 3, 6, and 12 months. High adherence was defined as completion of >75-100% of intervention components. Overall adherence rates were similar between BA and MEDS. At 6 months, among patients with >75-100% adherence who followed treatment as directed in both arms, BA was associated with higher Mental HRQoL (SF-12v2-MC: 5.22; 95% CI: 0.72 to 9.72; p = 0.023) and higher HF-specific HRQoL (KCCQ-OS: 16.08; 95% CI: 7.20 to 24.97; p < 0.001); (KCCQ-CS: 16.04; 95%CI: 7.05 to 25.02; p < 0.001) compared to MEDS. There were no significant differences in depressive symptoms or physical HRQoL at 6 months. INTERPRETATION: Both BA and MEDS were equally effective treatments for depression in HF. However, among highly adherent patients, BA was associated with greater improvements in mental and HF-specific HRQoL than MEDS. FUNDING/SUPPORT: The study was funded by PCORI Award Number: 2017C2-7716.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA(1); David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: Waguih.IsHak@cshs.org.
- Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Biostatistics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA(1).
- Department of Nursing Research, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
- Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA(1); Cedars-Sinai Center for Virtual Medicine and Health System Transformation, Los Angeles, CA, USA.
Förderung
- Patient-Centered Outcomes Research Institute
Zitieren
APA
IsHak, W. W., Hamilton, M. A., Diniz, M. A., Mirocha, J., Chernoff, R., Hedrick, R., Aronow, H., Darwish, T., Messineo, G., Pasini, M., Olanisa, L., Tetrault, E., Arun, A., Tessema, K. K., Harold, J. G., Ong, M. K., Spiegel, B., Wells, K., & Danovitch, I. (2026). Psychotherapy vs antidepressants in heart failure: Impact of adherence. Journal of Affective Disorders, 414, 122318. https://doi.org/10.1016/j.jad.2026.122318
Vancouver
IsHak WW, Hamilton MA, Diniz MA, Mirocha J, Chernoff R, Hedrick R, et al. Psychotherapy vs antidepressants in heart failure: Impact of adherence. Journal of Affective Disorders. 2026;414:122318. doi:10.1016/j.jad.2026.122318
BibTeX
@article{IsHak2026,
author = {IsHak, Waguih William and Hamilton, Michele A and Diniz, Marcio A and Mirocha, James and Chernoff, Robert and Hedrick, Rebecca and Aronow, Harriet and Darwish, Tarneem and Messineo, Gabrielle and Pasini, Mia and Olanisa, Linda and Tetrault, Ella and Arun, Ankith and Tessema, Kaleab K and Harold, John Gordon and Ong, Michael K and Spiegel, Brennan and Wells, Kenneth and Danovitch, Itai},
title = {Psychotherapy vs antidepressants in heart failure: Impact of adherence},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {414},
pages = {122318},
doi = {10.1016/j.jad.2026.122318}
}
EUVIMED